Alimera Sciences Signs Agreement To Distribute ILUVIEN® In The Middle East
December 15, 2015MEAgate will open an office for Alimera to support regulatory, medical affairs, and sales and marketing operations. This market holds great opportunity with a population exceeding 200 million, a high rate of diabetes, and developing healthcare systems.
More »
Veracyte Announces Positive Coverage Policy for the Afirma® Gene Expression Classifier from Health Care Service Corporation (HCSC)
December 14, 2015Health Care Service Corporation and Excellus BlueCross BlueShield in New York State issued positive coverage decisions for the Afirma GEC, bringing total number of insured lives covered for the test to nearly 175 million.
More »
Otonomy Announces FDA Approval of OTIPRIO(TM) for the Treatment of Pediatric Patients Undergoing Tympanostomy Tube Placement Surgery U.S. Commercial Launch Expected in the First Quarter of 2016
December 11, 2015OTIPRIO, a single-dose, physician-administered antibacterial, is the first product approved by the FDA for the treatment of pediatric patients with bilateral otitis media with effusion undergoing tympanostomy tube placement.
More »